Global Breast Lesion Localization Methods Market

Global Breast Lesion Localization Methods Market: Insights

Breast Lesion is mostly due to evolving lifestyles, increased use of contraceptive methods, and hence arise in the number of females seeking cosmetic operations related to breast. Technological developments in breast localization, expanding frequency of carcinoma and increase in carcinoma operations, an increasing proportion of state and non-government insurance policies, augmented consciousness amongst individuals for the evaluation of carcinoma, and breakthroughs of newest technologies are some of the primary reasons propelling the market for global breast lesion localization methods market. Governments in emerging nations are also substantially financing the construction and modernization of healthcare infrastructure, which provides chances to market participants.

Breast cancer cases are being reported increasingly across various countries by passing years. These breast cancer lesions develop due to many reasons, although, in recent years, it has been found out that greater exposure to radiation is becoming one of the common causes for the formation of lesions or internal injuries in the breast tissues. Also, science has proved the sensitivity and changing hormonal conditions in a female’s body and any sort of internal or external stress is the most common cause behind the causation of breast cancer lesions. Today, with the drastically changing lifestyle of these women in this highly globalizing and urbanizing world, significantly less focus is given to dietary plans, which can again cause internal stress-causing injuries to the tissues. This leads to a surge in demand for breast lesion localization methods.

Furthermore, as rightly mentioned earlier, any sort of external trauma, injury, infection, or inflammation can lead to breast cancer lesions. Also, excessive consumption of alcohol or excessive body fat during the adulthood and teenage years are reported to be common causes behind breast cancer. Besides all these factors, one more factor that prominently causes lesions is the genetic factor. Women with a genetic family history of breast cancer lesions are diagnosed with similar cases in their lifespans. These increasing causes behind the formation of lesions and the corresponding increase in the number of women with breast cancer require appropriate and immediate localization methods to deliver required treatments and medications.

The occurrence of carcinoma has increased significantly over the years and is expected to rise more in the coming years. Nevertheless, there has been no corresponding increase in the number of oncologists, with this instance being more prominent in developing nations.This scarcity of trained experts is expected to be a stumbling block for the growth of the breast lesion localization methods market throughout the forecast period. Regulatory concerns such as breast localization and product recalls may stymie market growth.

As per the World Cancer Research Fund and American Institute for Cancer Research, the 2018 database showcases that approximately 2 million breast cancer cases are reported every year. Amongst the group of various types of cancers, breast cancer is the second most reported or diagnosed cancer across the world among millions of women every year. Today, besides the increasing number of breast cancer lesion cases, there have been commendable improvements in infrastructural facilities to undertake advanced treatments and medicational processes. There has been a surge in the number of hospitals and cancer specialty clinics to deliver treatment to increasing breast cancer cases among women of diverse age groups. Alongside, governmental and non-governmental organizations have been funding extensively within the public as well as private medical facilities to cater to the increasing needs, right from diagnosing and locating lesions to delivering treatments for the same.

Moreover, with the increasing cases, countries worldwide are getting encouraged and are investing more funds in research and development to bring in new and advanced localization methods for diagnosing breast cancer lesions. The number of professionals, researchers, cancer specialists are also emerging at a higher rate in the medical and healthcare sectors of various nations across the world. All these factors are contributing tremendously to accelerating extensive growth in the breast lesion localization methods market.

Global Breast Lesion Localization Methods Market: By Type

Based on the type of method used for localization of breast lesions, the market is categorized as wire-guided, radioisotope, magnetic tracer, and others. Radioisotope includes radio-guided occult-lesion localization (ROLL), radioactive-seed localization (RSL), and others. Among these, the wire-guided type of method is drastically used across various healthcare verticals for breast lesion localization. Wire guided type holds the largest share in the breast lesion localization method market due to the features and characteristics attributed by it. The wire-guided technique was the first-ever method introduced approximately 50 years ago, mainly to assist the professionals or cancer specialists in locating or localizing the non-palpable and image-detected breast lesions. Today, the wire-guided technique is majorly used technique by surgeons, as it can be quickly and conveniently carried out under the guidance of ultrasound or mammography. Also, this technique facilitates accurate and real-time control of the wire position, thus enabling them to efficiently and precisely locate or localize the presence of breast lesions. This wire during the consultation is taped inside the skin to locate the injury or infectious lesion accurately, and this technique being the most painless out of all the rest of the localization methods, is preferred and utilized the most in the breast lesion localization methods market.

Global Breast Lesion Localization Methods Market: By Region

Based on regional segmentation. North America holds the largest share in the breast lesion localization methods market. According to the American Cancer Society, breast cancer is the most commonly diagnosed type of cancer among females within the North American region. Similar studies have proved that there are approximately 13% chances of breast cancer lesions among American women due to factors like genetics or increasing stress, obesity, improper diet, and many other reasons. One out of eight women across the North American region is detected with breast cancer every year. Followed by the North American region, European countries are second in the list of reporting women with breast cancer every year, thus utilizing the localization methods tremendously.

Although, the Asia Pacific region is expected to witness the fastest growth with respect to breast lesion localization methods compared to the rest of the regions. On average, countries in the Asia Pacific have females occupying more than 50% of their total population, significantly greater than North American or European developed countries' ratio. Considering this fact, the number of breast cancer cases reported in the APAC region has been witnessing a gradual increase over the past few decades. Also, research has proved the fact that women near to menopause stage or post-menopause stage are highly likely to develop breast lesions, and countries in the APAC region are having the majority of its population in the working-age group of 30 to 50 years, the women here are increasingly being diagnosed with breast cancer issues. Also, the increasing involvement of government and non-governmental organizations in the medical sectors of these countries is boosting the investments and funds for making improvements in infrastructural facilities. Also, there has been a gradual increase in the number of professionals and surgeons available in these developing countries, thus accelerating growth within the breast lesion localization methods market.

Global Breast Lesion Localization Methods Market: By Share & Competitor Analysis

Argon Medical Devices, Inc., SOMATEX Medical Technologies GmbH, C.R. Bard, Cook Medical,C.P. Medical, Cianna Medical, Inc., Laurane Medical, Matek Medical, Tsunami Medical, Biopsybell SRL, and Argon medical devices are some of the prominent competitors in the market.

Please note: This is not an exhaustive list of companies profiled in the report.